Jump to content [Access key 'm'] Jump to site navigation [Access key 'n'] Jump to Contact Us and Glossary [Access key 's'] Jump to Site Services and Sitemap [Access key 's'] Jump to local navigation [Access key 'l']
 

Investors

Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.



 

03/08/2010 Cyclacel Pharmaceuticals to present at the 22nd annual ROTH Capital OC Growth Stock Conference
02/17/2010 New Study in CCR demonstrates potential for seliciclib in treating breast cancer resistant to hormone therapy
02/01/2010 Cyclacel Pharmaceuticals to present at the 12th Annual BIO CEO & Investor Conference
01/27/2010 Cyclacel regains NASDAQ compliance
01/25/2010 Cyclacel completes previously announced registered direct offering
01/21/2010 Cyclacel to raise up to $7.9 million in registered direct offering
01/13/2010 Cyclacel completes previously announced registered direct offering
01/11/2010 Cyclacel to raise up to $9.5 million in registered direct offering
01/07/2010 Cyclacel’s seliciclib found effective against lung cancer cell Lines including K-RAS mutations
01/06/2010 Cyclacel Pharmaceuticals to present at OneMedForum 2010
Go to top  Go to top    Print page (opens in a new window)  Print page
 
Copyright © 1997-2009 Cyclacel Pharmaceuticals, Inc. All Rights Reserved  |  Site Map  |  Privacy  |  Disclaimer  |  Contact Us  |  Alerting Service